News

Among patients who received four-drug consolidation therapy, 84% had measurable residual disease (MRD)-negative status before ...
Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using ...
Is red light therapy the holy grail of holistic health remedies, or is it a scam? I took a deep dive to discover the benefits ...
After FDA approval in late 2023, the non-invasive liver tumor treatment histotripsy has been used at University of Michigan ...
STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways ...
In tests with mice, a protein derived from the virus boosted the immune system's ability to kill cancer cells.
Tolerance Bio is targeting an often-overlooked organ — the thymus — with cell therapy to help kids with DiGeorge syndrome, and potentially extend lifespan in adults.
CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...
A groundbreaking study has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161 ...
An innovative new treatment for tackling some of the toughest stomach cancers has shown promise in a phase 2 clinical trial, ...
The grant encompasses $100,000 each from the Life Sciences Entrepreneurship Center and Berkeley SkyDeck, with SkyDeck having ...
Researchers have identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an ...